Catalyst Wire Dossier Catalyst Wire Dossier

Remimazolam Besylate for Injection

remimazolam besylate
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Remimazolam Besylate for Injection, covering 2021-07-01 to 2021-07-01. Get the full timeline:

Most recent: Clinical Trial Update: The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients [Phase 3]

See pricing